GlassScriptPhysician profile
Erika George
NPI 1114467677
$5,949.02
in general payments reported to CMS, 2019-2025
41 companies · $1,401 in 2025
The $1,401 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $721 · 2022: $934 · 2023: $1,430 · 2024: $1,463 · 2025: $1,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,293.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $677.34 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $625.90 | 2023-2024 | Breztri, Airsupra, Lokelma |
| Pfizer INC. | $557.51 | 2021-2025 | |
| Lilly USA, LLC | $547.76 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $504.58 | 2021-2025 | |
| Glaxosmithkline, LLC. | $431.16 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $289.56 | 2021-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $266.21 | 2022-2024 | |
| Exact Sciences Corporation | $244.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $223.97 | 2021-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.83 | 2021-2025 | Jardiance |
| Dexcom, INC. | $136.35 | 2021-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $115.71 | 2021-2025 | Otezla, Repatha, Repatha |
| Daiichi Sankyo INC. | $115.44 | 2021-2023 | Injectafer |
| Abbott Laboratories | $109.70 | 2021-2025 | Proclaim, Freestyle Libre 3, Freestyle Libre 2 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.